July 20, 2022 – Molecular Testing Labs, a mission-driven, innovative health sciences company specializing in clinical diagnostics, announced they have chosen Eric Strafel as their CEO. Strafel has more than 25 years of experience building forward-thinking teams and scaling innovative technologies in startups through Fortune 50 companies. Previously, Strafel served as President and CEO of Aviall, creating the framework for the company’s 20/20 vision for future growth, resulting in three consecutive years of 20% growth and growing annual revenues to more than $5 billion during his tenure.
“Molecular Testing Labs is one of the most innovative health science companies in the industry and I’m proud to join their leadership team as CEO,” said Eric Strafel. “The future of healthcare is rooted in expanding access to care. Molecular’s proprietary self-collection solutions coupled with clinical processing and digital framework are key to securing quality, affordable healthcare for all communities who have limited access to testing and treatment. I’ve long been committed to creating opportunities for underserved communities and I’m excited to join Molecular Testing Labs to grow them into the most impactful lab in the US.”
In addition to holding C-suite positions in Fortune 50 companies and serving as CEO of Aviall, Strafel is also the founder of SUMMi7, a consultancy focused on helping businesses and teams with inclusion and sustainability built into their DNA to grow together in pursuit of a higher purpose. Prior to being tapped for CEO, Strafel completed a successful series of advisory engagements with the leadership team to establish a forward-looking growth strategy.
“Molecular Testing Labs was founded on principles of equity in care. Our model is to identify and address barriers in testing and clinical processing that lead to poor health outcomes and address those with innovation, and I can think of no one better than Eric Strafel to lead Molecular Testing Labs,” said Adam Blackwell, Co-Founder of Molecular Testing Labs. “Eric’s vision and track record of growing businesses exactly like ours and his long history in economic justice and equity work make him a perfect fit for Molecular, and we are lucky to have him.”